Understanding The 340B Program Requirements

November 8, 2021340B, 340B ESP, Bedside Prescription Delivery, Covered Entities, Drug Manufacturer Restrictions, Meds To Beds, Prescription Discounts, Requirements, Specialty Drugs, Specialty Pharmacy

What Is The 340B Drug Pricing Program? The 340B drug pricing program was created by Congress in 1992 to help fill revenue gaps experienced by healthcare providers operating on very low, or negative, margins — by providing significant discounts on prescription drugs. In a March, 2023 Fact Sheet, The American Hospital Association (AHA.org) noted, “The … Read More

340B Outlook For 2024: Change. Change. And More Change.

October 4, 2021340B, 340B ESP, Contract Pharmacy, Covered Entities, Drug Manufacturer Restrictions, Specialty Drugs, Specialty Drugs, Specialty Pharmacy, Specialty Pharmacy, TPA / TPAs

What we’ve learned. What it means for your 340B program. Between late 2019 and the end of 2023, ProxsysRx’s 340B Support program went from Zero to more than $500 million in savings generated for the hospitals and health systems we serve. In spite of drug manufacturer restrictions, every one of the 13 health systems we … Read More